Vial Announces the Addition of Dr. Egilius L.H. Spierings of MedVadis Research Corporation to their Central Nervous System Scientific Advisory Board

SAN FRANCISCO, March 8, 2023 /PRNewswire/ — Vial, a global tech-first CRO providing next-generation clinical trial management services, announced the addition of Egilius L.H. Spierings, MD, Ph.D., to Vial’s central nervous system (CNS) scientific advisory board (SAB). Dr. Spierings will…

Leave a Reply

Your email address will not be published. Required fields are marked *